SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-18-000166
Filing Date
2018-02-26
Accepted
2018-02-26 12:06:06
Documents
1
Group Members
ALAN FRAZIERBRIAN MORFITTFHM V, L.L.C.FHM V, L.P.FHM VII, L.L.C.FHM VII, L.P.FRAZIER HEALTHCARE VII, L.P.FRAZIER HEALTHCARE VII-A, L.P.JAMES TOPPERNADER NAININATHAN EVERYPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 FRAZIER HEALTHCARE V, L.P. / ANAPTYSBIO, INC. -- SCHEDULE 13D/A - AMEND. NO. 1 anaptys13da1_18179.htm SC 13D/A 391519
  Complete submission text file 0001072613-18-000166.txt   393480
Mailing Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 (206) 621-7200
Frazier Healthcare V, LP (Filed by) CIK: 0001341169 (see all company filings)

IRS No.: 830410164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Subject) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89797 | Film No.: 18639488
SIC: 2834 Pharmaceutical Preparations